FUNGAL INFECTION – STRONG MEDICIN

Categories: medical, MYCOLOGY
Wishlist Share
Share Course
Page Link
Share On Social Media

About Course

 Introduction to Pathologic Fungi: Classification and Clinical Relevance

Instructor: Eric, Stanford University

Course Description:
This course provides a foundational understanding of pathologic fungi and their relevance to human health. In this first video of a three-part series, learners will explore the classification of fungi that cause disease, examining their cellular structure, growth forms, and defining characteristics.

Through engaging explanations and practical examples, the course covers:

  • The general biology of fungi, including eukaryotic structure, cell walls, and membranes.
  • The differences between fungi and other kingdoms, highlighting why fungi are closer to animals than plants.
  • The major clinical categories of pathologic fungi: yeasts (e.g., Candida and Cryptococcus), molds (e.g., Aspergillus and Mucorales), dimorphic fungi (e.g., Histoplasma, Blastomyces, Coccidioides, Paracoccidioides, Sporothrix), dermatophytes, and Pneumocystis.
  • Key features distinguishing yeasts and molds, including reproduction, morphology, and clinical significance.
  • Practical insights into how fungi are classified for clinical purposes, with attention to the most relevant species for human disease.
  • Bacteria that mimic fungal infections, such as Nocardia and Actinomyces, and their clinical implications.

This module emphasizes a practical approach to fungal classification, preparing learners to understand fungal pathogenesis and anticipate clinical presentations. The following videos in the series will explore the specific diseases caused by these organisms and the therapeutic options available.

Learning Objectives:
By the end of this video, learners will be able to:

  1. Describe the general characteristics and cellular structure of fungi.
  2. Distinguish fungi from plants and animals based on morphology and nutritional strategy.
  3. Identify and categorize the five major clinical groups of pathologic fungi and representative species within each group.
Show More

What Will You Learn?

  • Understand the basic structure and classification of fungi and how they differ from bacteria and human cells.
  • Identify common fungal pathogens and the types of infections they cause (superficial, subcutaneous, systemic, opportunistic).
  • Recognize clinical features, risk factors, and diagnosis of major fungal infections (e.g., Candida, Aspergillus, dimorphic fungi).
  • Describe mycotoxins (mushroom poisoning, aflatoxins, ergot alkaloids) and their health effects.
  • List allergic disorders related to mold exposure such as asthma, ABPA, and hypersensitivity pneumonitis.
  • Distinguish scientific facts from myths (quackery) about fungi (e.g., false links to cancer or “candida overgrowth syndrome”).
  • Classify major antifungal drugs (polyenes, azoles, echinocandins) and understand their mechanisms of action.
  • Identify key antifungal drugs, their uses, side effects, and toxicities.
  • Learn how to choose appropriate antifungal therapy based on infection type and patient condition.
  • Understand the clinical approach to serious infections like candidemia and the importance of early treatment.

Course Content

An Overview of Fungal Infections
Fungal infections commonly affect immunocompromised patients and are usually subacute or chronic, with antibiotics generally ineffective. Major risk factors include transplants, chemotherapy, and critical illness, while minor factors include diabetes, malnutrition, and indwelling lines. They are classified into five categories: superficial, mucocutaneous, subcutaneous, deep primary, and deep opportunistic infections, each with distinct clinical features. Pulmonary and CNS infections are often caused by dimorphic fungi, while opportunistic infections like mucormycosis and invasive aspergillosis have high mortality. Diagnosis relies on microscopy, cultures, and specific antigen or antibody tests.

  • An Overview of Fungal Infections
    20:30
  • T F Q

Mycotoxins, Allergies, and Quackery
1. Mycotoxins from mushrooms, aflatoxins, and ergot alkaloids can cause severe health effects, including liver failure, neurotoxicity, and vasoconstriction. 2. Mushroom poisoning is hard to diagnose and can be life-threatening, while aflatoxins increase chronic cancer risk, and ergotism has historically caused mass outbreaks. 3. Mold exposure can trigger allergic disorders like asthma, ABPA, allergic fungal rhinitis, and hypersensitivity pneumonitis, though safe exposure limits are unclear. 4. Some claims linking fungi to conditions such as cancer, autoimmune diseases, or candidal overgrowth are unsupported and represent quackery. 5. Awareness of real fungal diseases versus pseudoscientific claims is essential for proper diagnosis and treatment.

Antifungals
* Antifungal drugs are grouped into three main classes: **polyenes**, **azoles**, and **echinocandins**, each targeting fungal cell structures. * Polyenes (e.g., amphotericin B) bind **ergosterol** and form membrane pores but are highly effective with significant toxicity (especially nephrotoxicity). * Azoles inhibit **ergosterol synthesis** and include drugs like fluconazole and voriconazole, with varied spectrum and common side effects like hepatotoxicity. * Echinocandins inhibit **β-1,3-glucan synthesis** in the cell wall and are effective against Candida with relatively fewer side effects but high cost. * Choice of antifungal depends on infection severity, organism, resistance, and patient factors, with early treatment crucial in serious infections like candidemia.

Student Ratings & Reviews

No Review Yet
No Review Yet